AlphaTON Capital Corp. (ATON)
NCM – Real vaqt narxi. Valyuta: USD
0.30
-0.02 (-7.71%)
Yopilishda: Mar 27, 2026, 4:00 PM EDT
0.31
+0.01 (4.77%)
Bozordan keyin: Mar 27, 2026, 7:44 PM EDT

NCM – Real vaqt narxi. Valyuta: USD
0.30
-0.02 (-7.71%)
Yopilishda: Mar 27, 2026, 4:00 PM EDT
0.31
+0.01 (4.77%)
Bozordan keyin: Mar 27, 2026, 7:44 PM EDT
AlphaTON Capital Corp. raqamli aktivlar xazina kompaniyasi sifatida faoliyat yuritadi. U The Open Network (TON) tokenlarining strategik zaxirasini yaratish va boshqarish hamda Telegram ekotizimini rivojlantirishga qaratilgan. Kompaniya ommaviy bozor investorlariga TON ekotizimi va Telegramning milliardlab foydalanuvchilarga ega platformasiga institutsional darajadagi kirish imkoniyatini taqdim etadi. Uning faoliyati tarmoqni tasdiqlash va staking operatsiyalarini, shuningdek, Telegramga asoslangan ilovalarni ishlab chiqishni, shuningdek, TONga asoslangan markazlashtirilmagan moliya protokollari, o'yin platformalari va biznes ilovalariga strategik investitsiyalarni o'z ichiga oladi. Kompaniya, shuningdek, barqaror davolash natijalariga erishish va bemorlarning hayot sifatini yaxshilash uchun ma'lum nazorat nuqtasi qarshilik yo'llariga qaratilgan turli terapiyalarni ishlab chiqmoqda. Kompaniya ilgari Portage Biotech Inc. nomi bilan tanilgan va 2025-yil sentyabr oyida AlphaTON Capital Corp. nomini o'zgartirgan. AlphaTON Capital Corp. Road Town, Britaniya Virdjin orollarida joylashgan.
| Ism | Lavozim |
|---|---|
| Adam Melero | Controller |
| Dr. Robert A. Kramer Ph.D. | Chief Scientific Officer |
| Mr. Fiorenzo A. Villani | Executive Chairman & Chief Investment Officer |
| Mr. Logan Ryan Golema | Chief Technology Officer |
| Mr. Peter Molloy | Chief Executive Officer of Cyncado Therapeutics Inc. |
| Mr. Wesley Allen Levitt C.F.A. | Chief Financial Officer |
| Mr. William De'Ath | Chief Partnership Officer |
| Ms. Brittany Kaiser |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-03-02 | 6-K | f6k_030226.htm |
| 2026-01-21 | 6-K/A | f6k_011526.htm |
| 2026-01-13 | 6-K | f6k_011226.htm |
| 2026-01-09 | 6-K | f6k_010926.htm |
| 2025-12-23 | 6-K | f6k_122325.htm |
| 2025-12-03 | F-3 | f3_112425.htm |
| 2025-11-21 | 6-K | f6k_112125.htm |
| 2025-11-06 | F-3 | f3_102725.htm |
| 2025-10-10 | F-3 | f3_100825.htm |
| 2025-10-07 | D |
| CEO & Director |